Prevention, ecstasy and related drugs
DrugInfo newsletter, volume 4 number 2, December 2005
This issue of DrugInfo looks at the topic of ecstasy and related drugs and prevention methods from various sources.
To view this newsletter you will need Adobe Acrobat Reader. If you do not have Adobe Acrobat Reader (version 9.3), click on the link below and follow the instructions to install this free software:

Contents
Working at "their" level—drug prevention in schools Kim Moritz, Point Zero Youth Services, Executive Program Coordinator
"Party drugs" or "ERDs"? The debate continues Guest editorial by Paul Dillon,Information/Media Liaison Manager, National Drug and Alcohol Research Centre, University of New South Wales
The beginning of the end? David Caldicott, Research Fellow, Emergency & Trauma Departments, Royal Adelaide Hospital and Convener of the OzTox Collaboration
Challenges and issues in emergency responses to ecstasy and related drug use Alan Eade, Ambulance Paramedic, Metropolitan Ambulance Service (Victoria)
Reflections on the development and implementation of an early warning system for ecstasy and related drug markets in Australia Stuart A. Kinnera and Louisa Degenhardtb
Ecstasy and related drug use in New Zealand—public health responses Ross Bell, Executive Director, New Zealand Drug Foundation, Te Tu-a-papa Tarukino o Aotearoa
The normalisation of adolescent recreational drug use in England Howard Parker, Consultant and Professor Emeritus, Manchester University, United Kingdom
Prevention research summaries: Ecstasy Research Summaries prepared by Mr Netzach Goren, Research Officer, Centre for Youth Drug Studies, Australian Drug Foundation
New frontiers for ERDs prevention—Towards cultural interventions Cameron Duff, Research Lead, Vancouver Coastal Health, Canada
Stimulants, neuroenablement and hope John Fitzgerald, Principal Research Fellow, Centre for Health and Society,The University of Melbourne
ERDs on Somazone Daria Healy-Aarons, Youth Resource Worker, Australian Drug Foundation
|